Genetics of Kidney Cancer (Renal Cell Cancer) (PDQ …
Posted: September 30, 2018 at 5:44 pm
More than 55% of VHL-affected individuals develop only multiple renal cell cysts. The VHL-associated RCCs that occur are characteristically multifocal and bilateral and present as a combined cystic and solid mass.[66] Among individuals with VHL, the cumulative RCC risk has been reported as 24% to 45% overall. RCCs smaller than 3 cm in this disease tend to be low grade (Fuhrman nuclear grade 2) and minimally invasive,[67] and their rate of growth varies widely.[68] An investigation of 228 renal lesions in 28 patients who were followed up for at least 1 year showed that transition from a simple cyst to a solid lesion was infrequent.[66] Complex cystic and solid lesions contained neoplastic tissue that uniformly enlarged. These data may be used to help predict the progression of renal lesions in VHL. Figure 1 depicts bilateral renal tumors in a patient with VHL.
Enlarge Figure 1. von Hippel-Lindau diseaseassociated renal cell cancers are characteristically multifocal and bilateral and present as a combined cystic and solid mass. Red arrow indicates a lesion with a solid and cystic component, and white arrow indicates a predominantly solid lesion.
Tumors larger than 3 cm may increase in grade as they grow, and metastasis may occur.[68,69] RCCs often remain asymptomatic for long intervals.
Patients can also develop pancreatic cysts, cystadenomas, and pancreatic NETs.[2] Pancreatic cysts and cystadenomas are not malignant, but pancreatic NETs possess malignant characteristics and are typically resected if they are 3 cm or larger (2 cm if located in the head of the pancreas).[70] A review of the natural history of pancreatic NETs shows that these tumors may demonstrate nonlinear growth characteristics.[71]
Retinal manifestations, first reported more than a century ago, were one of the first recognized aspects of VHL. Retinal hemangioblastomas (also known as capillary retinal angiomas) are one of the most frequent manifestations of VHL and are present in more than 50% of patients.[72] Retinal involvement is one of the earliest manifestations of VHL, with a mean age at onset of 25 years.[1,2] These tumors are the first manifestation of VHL in nearly 80% of affected individuals and may occur in children as young as 1 year.[2,73,74]
Retinal hemangioblastomas occur most frequently in the periphery of the retina but can occur in other locations such as the optic nerve, a location much more difficult to treat. Retinal hemangioblastomas appear as a bright orange spherical tumor supplied by a tortuous vascular supply. Nearly 50% of patients have bilateral retinal hemangioblastomas.[72] The median number of lesions per affected eye is approximately six.[75] Other retinal lesions in VHL can include retinal vascular hamartomas, flat vascular tumors located in the superficial aspect of the retina.[76]
Longitudinal studies are important for the understanding of the natural history of these tumors. Left untreated, retinal hemangioblastomas can be a major source of morbidity in VHL, with approximately 8% of patients [72] having blindness caused by various mechanisms, including secondary maculopathy, contributing to retinal detachment, or possibly directly causing retinal neurodegeneration.[77] Patients with symptomatic lesions generally have larger and more numerous retinal hemangioblastomas. Long-term follow-up studies demonstrate that most lesions grow slowly and that new lesions do not develop frequently.[75,78]
Hemangioblastomas are the most common disease manifestation in patients with VHL, affecting more than 70% of individuals. A prospective study assessed the natural history of hemangioblastomas.[79] The mean age at onset of CNS hemangioblastomas is 29.1 years (range, 773 y).[80] After a mean follow-up of 7 years, 72% of the 225 patients studied developed new lesions.[81] Fifty-one percent of existing hemangioblastomas remained stable. The remaining lesions exhibited heterogeneous growth rates, with cerebellar and brainstem lesions growing faster than those in the spinal cord or cauda equina. Approximately 12% of hemangioblastomas developed either peritumoral or intratumoral cysts, and 6.4% were symptomatic and required treatment. Increased tumor burden or total tumor number detected was associated with male sex, longer follow-up, and genotype (all P < .01). Partial germline deletions were associated with more tumors per patient than were missense variants (P < .01). Younger patients developed more tumors per year. Hemangioblastoma growth rate was higher in men than in women (P < .01). Figures 2 and 3 depict cerebellar and spinal hemangioblastomas, respectively, in patients with VHL.
Enlarge Figure 2. Hemangioblastomas are the most common disease manifestation in patients with von Hippel-Lindau disease. The left panel shows a sagittal view of brainstem and cerebellar lesions. The middle panel shows an axial view of a brainstem lesion. The right panel shows a cerebellar lesion (red arrow) with a dominant cystic component (white arrow).
Enlarge Figure 3. Hemangioblastomas are the most common disease manifestation in patients with von Hippel-Lindau disease. Multiple spinal cord hemangioblastomas are shown.
The rate of pheochromocytoma formation in the VHL patient population is 25% to 30%.[82,83] Of patients with VHL-associated pheochromocytomas, 44% developed disease in both adrenal glands.[84] The rate of malignant transformation is very low. Levels of plasma and urine normetanephrine are typically elevated in patients with VHL,[85] and approximately two-thirds will experience physical manifestations such as hypertension, tachycardia, and palpitations.[82] Patients with a partial loss of VHL function (Type 2 disease) are at higher risk of pheochromocytoma than are VHL patients with a complete loss of VHL function (Type 1 disease); the latter develop pheochromocytoma very rarely.[13,14,82,86] The rate of VHL germline pathogenic variants in nonsyndromic pheochromocytomas and paragangliomas was very low in a cohort of 182 patients, with only 1 of 182 patients ultimately diagnosed with VHL.[87]
Paragangliomas are rare in VHL patients but can occur in the head and neck or abdomen.[88] A review of VHL patients who developed pheochromocytomas and/or paragangliomas revealed that 90% of patients manifested pheochromocytomas and 19% presented with a paraganglioma.[84]
The mean age at diagnosis of VHL-related pheochromocytomas and paragangliomas is approximately 30 years,[83,89] and patients with multiple tumors were diagnosed more than a decade earlier than patients with solitary lesions in one series (19 vs. 34 y; P < .001).[89] Diagnosis of pheochromocytoma was made in patients as young as 5 years in one cohort,[83] providing a rationale for early testing. All 21 pediatric patients with pheochromocytomas in this 273-patient cohort had elevated plasma normetanephrines.[83]
VHL patients may develop multiple serous cystadenomas, pancreatic NETs, and simple pancreatic cysts.[1] VHL patients do not have an increased risk of pancreatic adenocarcinoma. Serous cystadenomas are benign tumors and warrant no intervention. Simple pancreatic cysts can be numerous and rarely cause symptomatic biliary duct obstruction. Endocrine function is nearly always maintained; occasionally, however, patients with extensive cystic disease requiring pancreatic surgery may ultimately require pancreatic exocrine supplementation.
Pancreatic NETs are usually nonfunctional but can metastasize (to lymph nodes and the liver). The risk of pancreatic NET metastasis was analyzed in a large cohort of patients, in which the mean age at diagnosis of a pancreatic NET was 38 years (range, 1668 y).[90] The risk of metastasis was lower in patients with small primary lesions (3 cm), in patients without an exon 3 pathogenic variant, and in patients whose tumor had a slow doubling time (>500 days). Nonfunctional pancreatic NETs can be followed by imaging surveillance with intervention when tumors reach 3 cm. Lesions in the head of the pancreas can be considered for surgery at a smaller size to limit operative complexity.
ELSTs are adenomatous tumors arising from the endolymphatic duct or sac within the posterior part of the petrous bone.[91] ELSTs are rare in the sporadic setting, but are apparent on imaging in 11% to 16% of patients with VHL. Although these tumors do not metastasize, they are locally invasive, eroding through the petrous bone and the inner ear structures.[91,92] Approximately 30% of VHL patients with ELSTs have bilateral lesions.[91,93]
ELSTs are an important cause of morbidity in VHL patients. ELSTs evident on imaging are associated with a variety of symptoms, including hearing loss (95% of patients), tinnitus (92%), vestibular symptoms (such as vertigo or disequilibrium) (62%), aural fullness (29%), and facial paresis (8%).[91,92] In approximately half of patients, symptoms (particularly hearing loss) can occur suddenly, probably as a result of acute intralabyrinthine hemorrhage.[92] Hearing loss or vestibular dysfunction in VHL patients can also present in the absence of radiologically evident ELSTs (approximately 60% of all symptomatic patients) and is believed to be a consequence of microscopic ELSTs.[91]
Hearing loss related to ELSTs is typically irreversible; serial imaging to enable early detection of ELSTs in asymptomatic patients and resection of radiologically evident lesions are important components in the management of VHL patients.[94,95] Surgical resection by retrolabyrinthine posterior petrosectomy is usually curative and can prevent onset or worsening of hearing loss and improve vestibular symptoms.[92,94]
Tumors of the broad ligament can occur in females with VHL and are known as papillary cystadenomas. These tumors are extremely rare, and fewer than 20 have been reported in the literature.[96] Papillary cystadenomas are histologically identical to epididymal cystadenomas commonly observed in males with VHL.[97] One important difference is that papillary cystadenomas are almost exclusively observed in patients with VHL, whereas epididymal cystadenomas in men can occur sporadically.[98] These tumors are frequently cystic, and although they become large, they generally have a fairly indolent behavior.
More than one-third of all cases of epididymal cystadenomas reported in the literature and most cases of bilateral cystadenomas have been reported in patients with VHL.[99] Among symptomatic patients, the most common presentation is a painless, slow-growing scrotal swelling. The differential diagnoses of epididymal tumors include adenomatoid tumor (which is the most common tumor in this site), metastatic ccRCC, and papillary mesothelioma.[100]
In a small series, histological analysis did not reveal features typically associated with malignancy, such as mitotic figures, nuclear pleomorphism, and necrosis. Lesions were strongly positive for CK7 and negative for RCC. Carbonic anhydrase IX (CAIX) was positive in all tumors. PAX8 was positive in most cases. These features were reminiscent of clear cell papillary RCC, a relatively benign form of RCC without known metastatic potential.[97]
Go here to read the rest:
Genetics of Kidney Cancer (Renal Cell Cancer) (PDQ ...
- Male roundworms are picky when choosing a mate, new research finds - Phys.org - March 12th, 2024
- Male fertility is declining. Here's what the latest research shows as to why - Yahoo Eurosport UK - March 12th, 2024
- Protein integral to sperm development and male fertility identified - EurekAlert - February 23rd, 2024
- The Y Chromosome Is Vanishing. A New Sex Gene May Be The Future of Men. - ScienceAlert - February 23rd, 2024
- Embracing the Bald: The Journey of Acceptance and the Battle Against Male Pattern Baldness - BNN Breaking - February 23rd, 2024
- Fruit flies give further insight into evolution of male genitalia driven by sexual selection - EurekAlert - February 5th, 2024
- Massive genetic study estimates the chance of dying from prostate cancer - Medical Xpress - January 28th, 2024
- Lean Gene Reviews (USA) Does This Weight Loss Supplement Work? LeanGene Ingredients, Price, Where to Buy? - Outlook India - April 8th, 2023
- The biggest shock was not having a uterus the film about intersex beauty queen Sharon-Rose Khumalo - The Guardian - March 23rd, 2023
- Male Definition & Meaning | Dictionary.com - January 25th, 2023
- Male Genitalia Pictures, Anatomy & Diagram | Body Maps - Healthline - January 25th, 2023
- 15 Alpha Male Traits Characteristics of Real Alpha Males - January 25th, 2023
- The 15 Best Sex Toys for Men, According to Experts - SELF - January 25th, 2023
- Diabetes is increasing in younger population, finds study: Doctors share early signs that might help in early medical intervention - Times of India - January 25th, 2023
- Sexual dimorphism - Wikipedia - December 28th, 2022
- Why Do Men Go Bald: Male Baldness Causes, Treatment, Prevention - December 28th, 2022
- African Americans - Wikipedia - December 28th, 2022
- Talking Glossary of Genetic Terms | NHGRI - Genome - December 12th, 2022
- Risk Factors for Breast Cancer in Men - American Cancer Society - December 12th, 2022
- We have the killers DNA, we just need a name: Genetic game changer offers hope for near-unsolvable Ontario cold cases - Toronto Star - December 12th, 2022
- Hair loss - Symptoms and causes - Mayo Clinic - November 26th, 2022
- Cell Size and Scale - University of Utah - November 26th, 2022
- We created the world's first donkey embryo using IVF in a bid to save species from extinction - The Conversation - November 18th, 2022
- Male infertility - Diagnosis and treatment - Mayo Clinic - October 16th, 2022
- Dangerous Male Sex Pills - CBS News - October 16th, 2022
- Drone (bee) - Wikipedia - October 16th, 2022
- Prestigious award advances OHSU research on impact of drug use over generations - OHSU News - October 16th, 2022
- Breast Cancer Awareness Month: The importance of getting to know your lemons - Bothell-Kenmore Reporter - October 16th, 2022
- Identification of hub genes and candidate herbal treatment in obesity through integrated bioinformatic analysis and reverse network pharmacology |... - October 16th, 2022
- Behind this Nobel prize is a very human story: theres a bit of Neanderthal in all of us - The Guardian - October 16th, 2022
- Column One: Why this UCLA professor is studying female animals to gain insights into women's health - Los Angeles Times - October 16th, 2022
- Books wrap: Simone Kaho on her new poetry collection and PTSD; a conversation with Richard Wolfe; and more - New Zealand Herald - October 16th, 2022
- The 2016 WHO Classification of Tumours of the Urinary System and Male ... - October 8th, 2022
- How to Tell If a Squirrel Is Male or Female | Sciencing - October 8th, 2022
- The Genetic Drivers Of Longevity In Mice, Humans And Worms - Science 2.0 - October 8th, 2022
- A Guide To The Best Fertility Supplements And Vitamins For Men - Forbes - October 8th, 2022
- Early Signs Of Male Plant And Female Plant-How To Identify The Difference? - The Island Now - October 8th, 2022
- Why Not All 'House of the Dragon' Mixed Race Targaryens Are Blonde - Newsweek - October 8th, 2022
- Study on the interaction preference between CYCD subclass and CDK family members at the poplar genome level | Scientific Reports - Nature.com - October 8th, 2022
- Calcium-Channel Blocker and Adenosine Modulator Use and Risk of Hospitalization in Bipolar Disorder - Psychiatric Times - October 8th, 2022
- Israel, A Pioneer In Agriculture Of The Future - I24NEWS - i24NEWS - October 8th, 2022
- Results: Limousin society's 50th anniversary show and sale - Agriland - October 8th, 2022
- Drug resistance and population structure of Plasmodium falciparum and Plasmodium vivax in the Peruvian Amazon | Scientific Reports - Nature.com - October 8th, 2022
- Do Supplements Help Hair Growth? We Asked An Expert - SheFinds - October 8th, 2022
- Genomic imprinting - Wikipedia - September 30th, 2022
- BRCA beyond breast cancer: links to prostate, pancreatic, other tumors - The Columbus Dispatch - September 30th, 2022
- Severe COVID-19Related Outcomes Found Worse in Men With RA - Medscape - September 30th, 2022
- Let the Bees Tell You. On the Holy Bible (For Beekeepers) of Buckfast Abbey - Literary Hub - September 30th, 2022
- Genetics | Ohio State Medical Center - September 5th, 2022
- Regular exercise may help women live longer, regardless of their genes - Medical News Today - September 5th, 2022
- Habsburg Jaw: The Horrific Consequences of 'Royal Inbreeding' in Europe - TheTealMango - September 5th, 2022
- Alpha Beast XL Reviews (USA & Canada): Is It Legitimate Or Scammer? Shocking Ingredients Alert! - Deccan Herald - September 5th, 2022
- Men More Prone to Cancer Than Women, But Why? - HealthDay News - August 11th, 2022
- For Some Dolphins, the Key to Mating is Rolling with a Tight, Noisy Crew - Scientific American - August 11th, 2022
- Sister's Liver, Mother's Kidney Helps Save Uttarakhand Man's Life - NDTV - August 11th, 2022
- Role of genetic testing in in-vitro fertilization - Express Healthcare - August 11th, 2022
- Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis | Scientific Reports -... - August 11th, 2022
- PRC1-mediated epigenetic programming is required to generate the ovarian reserve - Nature.com - August 11th, 2022
- Ashton Kutcher and Autoimmune Disease Vasculitis - Healthline - August 11th, 2022
- ROCKET PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com - August 11th, 2022
- Meet the Algae That Went from Male/Female to Hermaphroditic - The Scientist - August 3rd, 2022
- The Sex Appeal of Symmetric Songs | TS Digest | The Scientist - The Scientist - August 3rd, 2022
- Asexual Reproduction: Species Reproducing on Their Own are Susceptible to Dangerous Genetic Mutations - Nature World News - August 3rd, 2022
- Viewpoint: Why genetic engineering of livestock is compatible with the sustainable and human treatment of animals - Genetic Literacy Project - August 3rd, 2022
- Why Do We Get Old, and Can Aging Be Reversed? - Quanta Magazine - August 3rd, 2022
- New Feminist Considerations of Masculinity, Reviewed - The New Yorker - August 3rd, 2022
- Family at 'breaking point' amid difficulties caring for son with rare genetic disorder - The Mirror - August 3rd, 2022
- There are valid reasons so many Nebraska kids have spent their summers detasseling corn - Scottsbluff Star Herald - August 3rd, 2022
- Prehistoric roots of 'cold sore' virus traced through ancient herpes DNA - EurekAlert - August 3rd, 2022
- Funny Papers Again Column | Idiotologies vs The Review and Research Posse - King City Rustler - August 3rd, 2022
- 10 US Parks Where You Can Watch Wildlife In Its Natural Habitat - TheTravel - August 3rd, 2022
- Men Missing Y Chromosome Have High Heart Disease Risk Best Life - Best Life - July 26th, 2022
- Going to the Beach? Planning a Hike? Be Prepared: Men Will Be Much Hungrier! - Neuroscience News - July 26th, 2022
- THE BALANCED LIFE | Use common sense when digesting wellness advice | - The Voice of Pelham - July 26th, 2022
- Ecostani | Despite concerns, the Cheetah project is worth pursuing - Hindustan Times - July 26th, 2022
- To what extent human beings are morally responsible for the actions they take as a result of their innate and acquired influences - Teen Ink - July 26th, 2022
- How Fast Does Hair Grow? Know These Easy-Peasy Tips to Grow your Tresses - TheTealMango - July 26th, 2022
- BETTER KNOW A PREY-GO-NEESH: Up Close and Personal With Your New Condor Neighbors - Lost Coast Outpost - July 26th, 2022
- From the 'Burgh to the Gulf: Lions relocated in zoo breeding program - TribLIVE - July 26th, 2022
- Long Non-Coding RNAs ANRIL and HOTAIR Upregulation is Associated with | IJGM - Dove Medical Press - July 26th, 2022